title: Isoniazid-induced severe hepatotoxicity: an infrequent but preventable cause of liver failure in children treated for latent tuberculosis infection.
abstract: Isoniazid (INH) monotherapy has gained widespread acceptance as an efficacious therapy for latent tuberculosis infection (LTBI) especially in low-prevalence settings. Although INH related hepatotoxicity is well recognized, progression to severe liver dysfunction requiring care at a transplant center remains unpredictable. We report the management of a five year-old girl who developed progressive liver failure due to INH prophylaxis. This highlights the potential severity of INH related hepatic injury and underscores the significance of vigilant clinical monitoring throughout the duration of the therapy in children.
authors.affiliation: Department of Pediatrics, University of South Florida College of Medicine, Tampa, Florida, USA.
authors.forename: Dan
authors.initials: D
authors.lastname: Desrochers
authors.forename: Regino P
authors.initials: RP
authors.lastname: González-Peralta
authors.forename: Daniel T
authors.initials: DT
authors.lastname: McClenathan
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Wilsey
authors.forename: Allah
authors.initials: A
authors.lastname: Haafiz
keywords: hepatotoxicity; isoniazid; latent tuberculosis infection